Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

NEOCHEM BIO SOLUTIONS LTD.

NSE : NEOCHEMBSE : ISIN CODE : INE21UM01018Industry : ChemicalsHouse : Private

BSE0.000 (0 %)

PREV CLOSE ( ) NA

OPEN PRICE ( ) 0.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 0

TODAY'S LOW / HIGH ( )0.00 0.00

52 WK LOW / HIGH ( )0 0

NSE109.60-2.2 (-1.97 %)

PREV CLOSE( ) 111.80

OPEN PRICE ( ) 109.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 330000

TODAY'S LOW / HIGH( ) 106.25 113.00

52 WK LOW / HIGH ( )102.6 113.4

Select year

Particulars

Mar 2025

Mar 2024

Mar 2023

Operational & Financial Ratios

Earnings Per Share (Rs)

11.61

2.70

1.98

CEPS(Rs)

7.77

2.59

2.41

DPS(Rs)

0.00

Book NAV/Share(Rs)

29.59

17.98

14.84

Tax Rate(%)

24.47

32.59

29.34

Margin Ratios

Core EBITDA Margin(%)

15.58

9.80

8.77

EBIT Margin(%)

16.35

9.21

7.50

Pre Tax Margin(%)

12.19

4.37

3.15

PAT Margin (%)

9.21

2.95

2.23

Cash Profit Margin (%)

10.79

4.94

4.75

Performance Ratios

ROA(%)

10.84

3.14

2.12

ROE(%)

48.82

17.96

13.33

ROCE(%)

27.34

14.15

10.54

Asset Turnover(x)

1.18

1.07

0.95

Sales/Fixed Asset(x)

3.51

2.91

2.61

Working Capital/Sales(x)

9.22

10.63

17.48

Efficiency Ratios

Fixed Capital/Sales(x)

0.28

0.34

0.38

Receivable days

92.18

94.48

109.19

Inventory Days

90.99

98.91

113.09

Payable days

100.44

130.08

156.95

Valuation Parameters

PER(x)

0.00

PCE(x)

0.00

Price/Book(x)

0.00

Yield(%)

EV/Net Sales(x)

0.50

0.65

0.66

EV/Core EBITDA(x)

2.80

5.79

6.55

EV/EBIT(x)

3.07

7.04

8.75

EV/CE(x)

0.76

0.87

0.92

M Cap / Sales

0.00

Growth Ratio

Net Sales Growth(%)

37.66

26.89

0.00

Core EBITDA Growth(%)

120.31

41.84

0.00

EBIT Growth(%)

144.44

55.86

0.00

PAT Growth(%)

330.28

67.89

0.00

EPS Growth(%)

330.28

36.48

0.00

Financial Stability Ratios

Total Debt/Equity(x)

1.80

2.78

3.26

Current Ratio(x)

1.21

1.17

1.09

Quick Ratio(x)

0.67

0.62

0.58

Interest Cover(x)

3.93

1.90

1.72

Total Debt/Mcap(x)